{"d":{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Business(ID=20217462,Language='FR')","uri":"https://ws.parlament.ch/OData.svc/Business(ID=20217462,Language='FR')","type":"itsystems.Pd.DataServices.DataModel.Business"},"BusinessResponsibilities":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20217462,Language='FR')/BusinessResponsibilities"}},"RelatedBusinesses":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20217462,Language='FR')/RelatedBusinesses"}},"BusinessRoles":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20217462,Language='FR')/BusinessRoles"}},"Publications":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20217462,Language='FR')/Publications"}},"LegislativePeriods":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20217462,Language='FR')/LegislativePeriods"}},"Sessions":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20217462,Language='FR')/Sessions"}},"Preconsultations":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20217462,Language='FR')/Preconsultations"}},"Bills":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20217462,Language='FR')/Bills"}},"Councils":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20217462,Language='FR')/Councils"}},"BusinessTypes":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20217462,Language='FR')/BusinessTypes"}},"Votes":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20217462,Language='FR')/Votes"}},"SubjectsBusiness":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20217462,Language='FR')/SubjectsBusiness"}},"BusinessStates":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20217462,Language='FR')/BusinessStates"}},"Council":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20217462,Language='FR')/Council"}},"Transcripts":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20217462,Language='FR')/Transcripts"}},"ID":20217462,"Language":"FR","BusinessShortNumber":"21.7462","BusinessType":14,"BusinessTypeName":"Heure des questions. Question","BusinessTypeAbbreviation":"Qst.","Title":"Avant la votation du 13 juin : comment le Conseil f\u00e9d\u00e9ral peut-il pr\u00e9tendre conna\u00eetre le nombre exact de pesticides perturbateurs endocriniens autoris\u00e9s en Suisse ?","Description":null,"InitialSituation":null,"Proceedings":null,"DraftText":null,"SubmittedText":"<p>Le Conseil f\u00e9d\u00e9ral r\u00e9pond \u00e0 ma question 21.7191\u00a0: \"En Suisse, trois substances actives, consid\u00e9r\u00e9es comme des perturbateurs endocriniens [PE], sont encore admises dans la composition de produits phytosanitaires.\"</p><p>- De quelles substances s'agit-il, quels effets endocriniens leur sont attribu\u00e9s et dans quelles quantit\u00e9s peuvent-elles d\u00e9j\u00e0 avoir un effet en tant que PE\u00a0?</p><p>- Quels pesticides autoris\u00e9s en Suisse ont d\u00e9j\u00e0 \u00e9t\u00e9 test\u00e9s pour leurs effets endocriniens et approuv\u00e9s comme s\u00fbrs\u00a0?</p>","ReasonText":null,"DocumentationText":null,"MotionText":null,"FederalCouncilResponseText":"<p>Les trois substances \u00e9voqu\u00e9es dans la r\u00e9ponse \u00e0 la question 21.7191 sont les suivantes\u00a0: chlorotholuron, \u00e9poxiconazol et thiacloprid. L'admission des deux derni\u00e8res substances a \u00e9t\u00e9 retir\u00e9e avec effet au 1er juillet 2021. Le r\u00e9examen du chlorotholuron est en cours dans l'UE. La classification de ces trois substances parmi les substances ayant des effets perturbateurs endocriniens potentiels est fond\u00e9e sur les anciens crit\u00e8res int\u00e9rimaires, \u00e0 savoir que ces substances sont class\u00e9es comme agents canc\u00e9rog\u00e8nes de cat\u00e9gorie 2 et toxiques pour la reproduction de cat\u00e9gorie 2. Depuis 2019, de nouveaux crit\u00e8res ont \u00e9t\u00e9 adopt\u00e9s dans l'UE. Jusqu'\u00e0 ce jour, les substances suivantes ont \u00e9t\u00e9 r\u00e9examin\u00e9es par l'UE selon ces crit\u00e8res et consid\u00e9r\u00e9es comme n'ayant pas d'effets perturbateurs endocriniens\u00a0: 1-MCP, alpha-cypermethrin, \u00e9toxazole, isoxaflutole.</p>","FederalCouncilProposal":null,"FederalCouncilProposalText":null,"FederalCouncilProposalDate":"\/Date(1623024000000)\/","SubmittedBy":"Python Valentine","BusinessStatus":229,"BusinessStatusText":"Liquid\u00e9","BusinessStatusDate":"\/Date(1623024000000)\/","ResponsibleDepartment":8,"ResponsibleDepartmentName":"D\u00e9partement de l'\u00e9conomie, de la formation et de la recherche","ResponsibleDepartmentAbbreviation":"DEFR","IsLeadingDepartment":true,"Tags":"52|55|2841","Category":null,"Modified":"\/Date(1758107589170)\/","SubmissionDate":"\/Date(1622592000000)\/","SubmissionCouncil":1,"SubmissionCouncilName":"Conseil national","SubmissionCouncilAbbreviation":"CN","SubmissionSession":5110,"SubmissionLegislativePeriod":51,"FirstCouncil1":1,"FirstCouncil1Name":"Conseil national","FirstCouncil1Abbreviation":"CN","FirstCouncil2":null,"FirstCouncil2Name":null,"FirstCouncil2Abbreviation":null,"TagNames":"Environnement|Agriculture|Sant\u00e9"}}